SlideShare uma empresa Scribd logo
1 de 14
PHARMACOKINETICS
Prepared By : Guided By :
Parth Patel Dr. Hitesh Jain
(M. Pharm Sem.1) M.pharm ,Ph.D
Forwarded By:
Dr.U.M. Upadhyay
M.pharm ,Ph.D
Sigma Institute Of Pharmacy, Vadodara
CONTENTS
Biological Half Life
Volume Of Distribution
Renal Clearance
Total Body Clearance
Plasma Protein Binding
Absorption Rate Constant
Elimination Rate Constant
Conclusion
References
PHARMACOKINETICS:
 Definition: the activity or fate of drugs in the body over a period of
time, including the processes of absorption, distribution, localization in
tissues, biotransformation and excretion.
 The study of pharmacokinetics involves both experimental and
theoretical approaches. The experimental aspect of pharmacokinetics
involves the development of biologic sampling techniques, analytical
methods for the measurement of drugs and metabolites, and procedures
that facilitate data collection and manipulation. The theoretical aspect
of pharmacokinetics involves the development of pharmacokinetic
models that predict drug disposition after drug administration.
BIOLOGICAL HALF LIFE
 Basic Concept And Importance Of Biological Half Life :
 Half-life is the time taken for the drug concentration to fall to half its original value
 ZERO ORDER t1/2 = 0.5Co
Ko
Co = initial drug concentration
Ko = zero order rate constant
VOLUME OF DISTRIBUTION
 It is defined as the hypothetical volume of body fluid into which a drug is dissolved or
distributed. It is also known as apparent volume of distribution because all parts of the body
equilibrated with the drug do not have equal drug concentration.
 Drug in circulation distributes to various organs and tissues. When the process of distribution
is complete ,different organs and tissues contain varying concentrations of drugs which can
be determined by the volume of tissues in which the drug is present.
 There is a relationship between concentration of drug in plasma (C)and amount of drug in
the body (X).
𝜲 𝜶 𝑪 so 𝜲= Vd•c
where 𝜲 = amount of drug in the body
Vd = volume of distribution
c = concentration of drug in plasma
amount of drug in the body(X)
Apparent volume of distribution(Vd)=
plasma drug concentration(C)
Vd = X
C
RENAL CLEARANCE
 Renal clearance CLR is defined as the volume of plasma that is cleared of drug per unit of
time through the kidney. Similarly, renal clearance may be defined as a constant fraction of
the V D in which the drug is contained that is excreted by the kidney per unit of time. More
simply, renal clearance is defined as the urinary drug excretion rate divided by the plasma
drug concentration .
 An alternative approach to obtaining equation is to consider the mass balance of drug
cleared by the kidney and ultimately excreted in the urine. For any drug cleared through
the kidney, the rate of the drug passing through kidney (via filtration, reabsorption, and/or
active secretion) must equal the rate of drug excreted in the urine.
 Rate of drug passing through kidney = rate of drug excreted
CL renal = [(Glomerular filtration rate + Tubular secretion rate) – Tubular reabsorption rate] / Cp
If the renal clearance of the drug is higher than the physiological creatinine
clearance (120-130 ml/min), that time we can say that the tubular secretion
helps and contributes the elimination of the drug additionally to filtration.
In early newborns and newborns, glomerular filtration and tubular
secretion mechanisms
are immature and not sufficient.
Renal Clearence (CLR) =
V x CU
t x CP
V= collected urine volume
t= duration to collect the urine
CP= plasma concentration of the drug
CU= urine concentration of the drug
TOTAL BODY CLEARANCE
 Total body clearance is a pharmacokinetic term for describing drug elimination from
the body without identifying the mechanism of the process. Total body clearance
(body clearance, total body clearance, or cl T) considers the entire body as a single
drug-eliminating system from which many unidentified elimination processes may
occur. Instead of describing the drug elimination rate in terms of amount of drug
removed per time unit (eg, mg/min), Total body clearance is described in terms of
volume of fluid clear of drug per time unit (eg, ml/min).
 There are several definitions of clearance, which are similarly based on volume of
drug removed per unit time. The simplest concept of clearance regards the body as
a space that contains a definite volume of body fluid (apparent volume of
distribution, V D) in which the drug is dissolved. Total body clearance is defined as
the fixed volume of fluid (containing the drug) cleared of drug per unit of time.
 The units for clearance are volume/time (eg, ml/min, L/hr). For example, if the cl
T of penicillin is 15 ml/min in a patient and penicillin has a V D of 12 L, then from
the clearance definition, 15 ml of the 12 L will be cleared of drug per minute.
 Alternatively, cl t may be defined as the rate of drug elimination divided by the
plasma drug concentration. This definition expresses drug elimination in terms of
the volume of plasma eliminated of drug per unit time. This definition is a practical
way to calculate clearance based on plasma drug concentration data.
 Where d e is the amount of drug eliminated and dd e/dt is the rate of elimination.
PLASMA PROTEIN BINDING
ABSORPTION RATE CONSTANT
ELIMINATION RATE CONSTANT
 The elimination rate constant (k) is the fraction of drug in the body which is removed
per unit time.
 The rate of elimination for most drugs from a tissue or from the body is a first-order
process, in which the rate of elimination is dependent on the amount or concentration
of drug present. The elimination rate constant, k, is a first-order elimination rate
constant with units of time– 1 (eg, hr– 1 or 1/hr). Generally, the parent or active drug is
measured in the vascular compartment. Total removal or elimination of the parent drug
from this compartment is effected by metabolism (biotransformation) and excretion.
The elimination rate constant represents the sum of each of these processes:
References
1. Martin’s physical pharmacy and pharmaceutical sciences ; 6th edition ; by Patrick
J.Sinko and Yashveer Singh ; Lippincott Williams and wilkins ; P.No ;258-299
2. Pharmaceutical calculations ;13th edition ;by Howard C.Ansel ;Lippincott Williams
and wilkins ; P.No. ;
3. Pharmaceutics; the sciences of dosage form design ; 2nd edition; edited by m.e.
Aulton ;Churchill Livingstone; P.No.; 211-289
4. Applied biopharmaceutics and pharmacokinetics ; 5th edition ;by Leon Shargel ,
Susanna wu pong, Andrew B.C. Yu ; P.No.
5. R brahmankar, s jaiswal

Mais conteúdo relacionado

Mais procurados

one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model pptSheetal Jha
 
CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx
CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptxCONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx
CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptxNamrataSawant19
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing BioavailabilityDibrugarh University
 
Physicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of DrugsPhysicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of DrugsSuraj Choudhary
 
Bioequivalence studies
Bioequivalence studiesBioequivalence studies
Bioequivalence studiesSujit Patel
 
Gastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemGastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemDr Gajanan Sanap
 
methods of determining drug absorption ppt
methods of determining drug absorption pptmethods of determining drug absorption ppt
methods of determining drug absorption ppttenzin jangchuk
 
Pharmacokinetic and pharmacodynamic drug interactions
Pharmacokinetic and pharmacodynamic drug interactionsPharmacokinetic and pharmacodynamic drug interactions
Pharmacokinetic and pharmacodynamic drug interactionsSajalChowdhury4
 
Non linear Pharmacokinetics
Non linear PharmacokineticsNon linear Pharmacokinetics
Non linear PharmacokineticsAreej Abu Hanieh
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesDr. Kunal Chitnis
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modellingPriyankaDabirBharadk
 

Mais procurados (20)

one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model ppt
 
CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx
CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptxCONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx
CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx
 
Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 
Concept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic modelConcept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic model
 
Physicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of DrugsPhysicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of Drugs
 
Non compartment model
Non compartment modelNon compartment model
Non compartment model
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Bioequivalence studies
Bioequivalence studiesBioequivalence studies
Bioequivalence studies
 
Gastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemGastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery System
 
Bioequivalence Studies
Bioequivalence StudiesBioequivalence Studies
Bioequivalence Studies
 
methods of determining drug absorption ppt
methods of determining drug absorption pptmethods of determining drug absorption ppt
methods of determining drug absorption ppt
 
Pharmacokinetic and pharmacodynamic drug interactions
Pharmacokinetic and pharmacodynamic drug interactionsPharmacokinetic and pharmacodynamic drug interactions
Pharmacokinetic and pharmacodynamic drug interactions
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
MECHANISMS OF DRUG ABSORPTION
MECHANISMS OF DRUG  ABSORPTIONMECHANISMS OF DRUG  ABSORPTION
MECHANISMS OF DRUG ABSORPTION
 
Bio availability and bio equivalence
Bio availability and bio equivalenceBio availability and bio equivalence
Bio availability and bio equivalence
 
Non linear Pharmacokinetics
Non linear PharmacokineticsNon linear Pharmacokinetics
Non linear Pharmacokinetics
 
Basics of Pharmacokinetics
Basics of PharmacokineticsBasics of Pharmacokinetics
Basics of Pharmacokinetics
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence Studies
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modelling
 

Destaque

Pharmacokinetics ppt
Pharmacokinetics pptPharmacokinetics ppt
Pharmacokinetics pptNITISH SHAH
 
Drug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacologyDrug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacologyVishnu Priya
 
Clearance Mechanism (Biopharmaceutics)
Clearance Mechanism (Biopharmaceutics)Clearance Mechanism (Biopharmaceutics)
Clearance Mechanism (Biopharmaceutics)HadeelSalah
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment ModellingPallavi Kurra
 
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]BADAR UDDIN UMAR
 
Philips case study
Philips case studyPhilips case study
Philips case studyAditya Raman
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionchiranjibi68
 

Destaque (14)

Pharmacokinetics ppt
Pharmacokinetics pptPharmacokinetics ppt
Pharmacokinetics ppt
 
1 Pharmacology Pharmacokinetics
1 Pharmacology   Pharmacokinetics1 Pharmacology   Pharmacokinetics
1 Pharmacology Pharmacokinetics
 
Drug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacologyDrug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacology
 
Drug Clearance
Drug ClearanceDrug Clearance
Drug Clearance
 
Clearance Mechanism (Biopharmaceutics)
Clearance Mechanism (Biopharmaceutics)Clearance Mechanism (Biopharmaceutics)
Clearance Mechanism (Biopharmaceutics)
 
Excretion of drug (VK)
Excretion of drug (VK)Excretion of drug (VK)
Excretion of drug (VK)
 
Drug distribution & clearance
Drug distribution & clearanceDrug distribution & clearance
Drug distribution & clearance
 
Pharmacokinetics: Lecture One
Pharmacokinetics: Lecture OnePharmacokinetics: Lecture One
Pharmacokinetics: Lecture One
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
Clinical Pharmacokinetics-I [half life, order of kinetics, steady state]
 
Philips case study
Philips case studyPhilips case study
Philips case study
 
Nasal drug delivery
Nasal drug deliveryNasal drug delivery
Nasal drug delivery
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 

Semelhante a Pharmacokinetics ppt

ONE COMPARTMENT MODEL.pptx
ONE COMPARTMENT MODEL.pptxONE COMPARTMENT MODEL.pptx
ONE COMPARTMENT MODEL.pptxarti10aug
 
One compartment model intro
One compartment model introOne compartment model intro
One compartment model introPankaj Nerkar
 
one compartment open model
one compartment open modelone compartment open model
one compartment open modelSUJITHA MARY
 
dokumen.tips_parameter-farmakokinetik-5785c20de078f.ppt
dokumen.tips_parameter-farmakokinetik-5785c20de078f.pptdokumen.tips_parameter-farmakokinetik-5785c20de078f.ppt
dokumen.tips_parameter-farmakokinetik-5785c20de078f.pptJeanM24
 
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptxCO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptxSamwel Samwel
 
COMPARTMENT BODY MEDELING-1.pptx
COMPARTMENT  BODY MEDELING-1.pptxCOMPARTMENT  BODY MEDELING-1.pptx
COMPARTMENT BODY MEDELING-1.pptxSumant Saini
 
BIOAVAILABILITY IN A NUTSHELL.pdf
BIOAVAILABILITY IN A NUTSHELL.pdfBIOAVAILABILITY IN A NUTSHELL.pdf
BIOAVAILABILITY IN A NUTSHELL.pdfsamthamby79
 
lecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptxlecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptxWaqasAhmad535
 
1612188029641020.pptx
1612188029641020.pptx1612188029641020.pptx
1612188029641020.pptxMuhannadOmer
 
Bioavailability studies lecture7
Bioavailability studies lecture7Bioavailability studies lecture7
Bioavailability studies lecture7homebwoi
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacyemebetnigatu1
 
4_2018_11_05!08_27_52_PM.pdf
4_2018_11_05!08_27_52_PM.pdf4_2018_11_05!08_27_52_PM.pdf
4_2018_11_05!08_27_52_PM.pdfMrAlex28
 

Semelhante a Pharmacokinetics ppt (20)

Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
ONE COMPARTMENT MODEL.pptx
ONE COMPARTMENT MODEL.pptxONE COMPARTMENT MODEL.pptx
ONE COMPARTMENT MODEL.pptx
 
2.pharmacokinetics
2.pharmacokinetics2.pharmacokinetics
2.pharmacokinetics
 
TOXICOKINETICS
TOXICOKINETICSTOXICOKINETICS
TOXICOKINETICS
 
Renal clearance
Renal clearanceRenal clearance
Renal clearance
 
One compartment model intro
One compartment model introOne compartment model intro
One compartment model intro
 
one compartment open model
one compartment open modelone compartment open model
one compartment open model
 
Pocket Guide: Pharmacokinetics Made Easy - sample
Pocket Guide: Pharmacokinetics Made Easy - sample Pocket Guide: Pharmacokinetics Made Easy - sample
Pocket Guide: Pharmacokinetics Made Easy - sample
 
dokumen.tips_parameter-farmakokinetik-5785c20de078f.ppt
dokumen.tips_parameter-farmakokinetik-5785c20de078f.pptdokumen.tips_parameter-farmakokinetik-5785c20de078f.ppt
dokumen.tips_parameter-farmakokinetik-5785c20de078f.ppt
 
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptxCO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
 
COMPARTMENT BODY MEDELING-1.pptx
COMPARTMENT  BODY MEDELING-1.pptxCOMPARTMENT  BODY MEDELING-1.pptx
COMPARTMENT BODY MEDELING-1.pptx
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
BIOAVAILABILITY IN A NUTSHELL.pdf
BIOAVAILABILITY IN A NUTSHELL.pdfBIOAVAILABILITY IN A NUTSHELL.pdf
BIOAVAILABILITY IN A NUTSHELL.pdf
 
lecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptxlecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptx
 
1612188029641020.pptx
1612188029641020.pptx1612188029641020.pptx
1612188029641020.pptx
 
Bioavailability studies lecture7
Bioavailability studies lecture7Bioavailability studies lecture7
Bioavailability studies lecture7
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
 
4_2018_11_05!08_27_52_PM.pdf
4_2018_11_05!08_27_52_PM.pdf4_2018_11_05!08_27_52_PM.pdf
4_2018_11_05!08_27_52_PM.pdf
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
 

Último

How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 

Último (20)

How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 

Pharmacokinetics ppt

  • 1. PHARMACOKINETICS Prepared By : Guided By : Parth Patel Dr. Hitesh Jain (M. Pharm Sem.1) M.pharm ,Ph.D Forwarded By: Dr.U.M. Upadhyay M.pharm ,Ph.D Sigma Institute Of Pharmacy, Vadodara
  • 2. CONTENTS Biological Half Life Volume Of Distribution Renal Clearance Total Body Clearance Plasma Protein Binding Absorption Rate Constant Elimination Rate Constant Conclusion References
  • 3. PHARMACOKINETICS:  Definition: the activity or fate of drugs in the body over a period of time, including the processes of absorption, distribution, localization in tissues, biotransformation and excretion.  The study of pharmacokinetics involves both experimental and theoretical approaches. The experimental aspect of pharmacokinetics involves the development of biologic sampling techniques, analytical methods for the measurement of drugs and metabolites, and procedures that facilitate data collection and manipulation. The theoretical aspect of pharmacokinetics involves the development of pharmacokinetic models that predict drug disposition after drug administration.
  • 4. BIOLOGICAL HALF LIFE  Basic Concept And Importance Of Biological Half Life :  Half-life is the time taken for the drug concentration to fall to half its original value  ZERO ORDER t1/2 = 0.5Co Ko Co = initial drug concentration Ko = zero order rate constant
  • 5. VOLUME OF DISTRIBUTION  It is defined as the hypothetical volume of body fluid into which a drug is dissolved or distributed. It is also known as apparent volume of distribution because all parts of the body equilibrated with the drug do not have equal drug concentration.  Drug in circulation distributes to various organs and tissues. When the process of distribution is complete ,different organs and tissues contain varying concentrations of drugs which can be determined by the volume of tissues in which the drug is present.  There is a relationship between concentration of drug in plasma (C)and amount of drug in the body (X). 𝜲 𝜶 𝑪 so 𝜲= Vd•c where 𝜲 = amount of drug in the body Vd = volume of distribution c = concentration of drug in plasma
  • 6. amount of drug in the body(X) Apparent volume of distribution(Vd)= plasma drug concentration(C) Vd = X C
  • 7. RENAL CLEARANCE  Renal clearance CLR is defined as the volume of plasma that is cleared of drug per unit of time through the kidney. Similarly, renal clearance may be defined as a constant fraction of the V D in which the drug is contained that is excreted by the kidney per unit of time. More simply, renal clearance is defined as the urinary drug excretion rate divided by the plasma drug concentration .  An alternative approach to obtaining equation is to consider the mass balance of drug cleared by the kidney and ultimately excreted in the urine. For any drug cleared through the kidney, the rate of the drug passing through kidney (via filtration, reabsorption, and/or active secretion) must equal the rate of drug excreted in the urine.  Rate of drug passing through kidney = rate of drug excreted
  • 8. CL renal = [(Glomerular filtration rate + Tubular secretion rate) – Tubular reabsorption rate] / Cp If the renal clearance of the drug is higher than the physiological creatinine clearance (120-130 ml/min), that time we can say that the tubular secretion helps and contributes the elimination of the drug additionally to filtration. In early newborns and newborns, glomerular filtration and tubular secretion mechanisms are immature and not sufficient. Renal Clearence (CLR) = V x CU t x CP V= collected urine volume t= duration to collect the urine CP= plasma concentration of the drug CU= urine concentration of the drug
  • 9. TOTAL BODY CLEARANCE  Total body clearance is a pharmacokinetic term for describing drug elimination from the body without identifying the mechanism of the process. Total body clearance (body clearance, total body clearance, or cl T) considers the entire body as a single drug-eliminating system from which many unidentified elimination processes may occur. Instead of describing the drug elimination rate in terms of amount of drug removed per time unit (eg, mg/min), Total body clearance is described in terms of volume of fluid clear of drug per time unit (eg, ml/min).  There are several definitions of clearance, which are similarly based on volume of drug removed per unit time. The simplest concept of clearance regards the body as a space that contains a definite volume of body fluid (apparent volume of distribution, V D) in which the drug is dissolved. Total body clearance is defined as the fixed volume of fluid (containing the drug) cleared of drug per unit of time.
  • 10.  The units for clearance are volume/time (eg, ml/min, L/hr). For example, if the cl T of penicillin is 15 ml/min in a patient and penicillin has a V D of 12 L, then from the clearance definition, 15 ml of the 12 L will be cleared of drug per minute.  Alternatively, cl t may be defined as the rate of drug elimination divided by the plasma drug concentration. This definition expresses drug elimination in terms of the volume of plasma eliminated of drug per unit time. This definition is a practical way to calculate clearance based on plasma drug concentration data.  Where d e is the amount of drug eliminated and dd e/dt is the rate of elimination.
  • 13. ELIMINATION RATE CONSTANT  The elimination rate constant (k) is the fraction of drug in the body which is removed per unit time.  The rate of elimination for most drugs from a tissue or from the body is a first-order process, in which the rate of elimination is dependent on the amount or concentration of drug present. The elimination rate constant, k, is a first-order elimination rate constant with units of time– 1 (eg, hr– 1 or 1/hr). Generally, the parent or active drug is measured in the vascular compartment. Total removal or elimination of the parent drug from this compartment is effected by metabolism (biotransformation) and excretion. The elimination rate constant represents the sum of each of these processes:
  • 14. References 1. Martin’s physical pharmacy and pharmaceutical sciences ; 6th edition ; by Patrick J.Sinko and Yashveer Singh ; Lippincott Williams and wilkins ; P.No ;258-299 2. Pharmaceutical calculations ;13th edition ;by Howard C.Ansel ;Lippincott Williams and wilkins ; P.No. ; 3. Pharmaceutics; the sciences of dosage form design ; 2nd edition; edited by m.e. Aulton ;Churchill Livingstone; P.No.; 211-289 4. Applied biopharmaceutics and pharmacokinetics ; 5th edition ;by Leon Shargel , Susanna wu pong, Andrew B.C. Yu ; P.No. 5. R brahmankar, s jaiswal